Saturday , December 14 2019
Home / BUSINESS / FDC receives USFDA’s approval for Dorzolamide and Timolol Ophthalmic Solution
FDC receives USFDA’s approval for Dorzolamide and Timolol Ophthalmic Solution

FDC receives USFDA’s approval for Dorzolamide and Timolol Ophthalmic Solution

 

FDC has been granted ANDA approval by United States Food and Drug Administration (USFDA), for Dorzolamide and Timolol Ophthalmic Solution USP 22.3mg/6.83mg per ml, a generic version of Cosopt of Oak Pharmaceuticals Inc.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).